Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.

Helmut W. Ott(University Hospital Innsbruck), Karl Illmensee(The Wistar Institute), S. Fessler, Peter Schwaerzler, Bettina Sarg, Elisabeth Mueller‐Holzner, A. Bergant(Universität Innsbruck), Alain G. Zeimet, Herbert Lindner, Christian Marth(Nordic Society of Gynecologic Oncology), Burkhard Abendstein

PubMed

November 1, 2003

Cited by 79

Related Papers

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

|New England Journal of Medicine|2016|2.5k

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

|Annals of Oncology|2015|1.4k

Normal genetically mosaic mice produced from malignant teratocarcinoma cells.

|Proceedings of the National Academy of Sciences|1975|1.2k

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer

|International Journal of Gynecological Cancer|2015|757

Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts.

|Proceedings of the National Academy of Sciences|1976|469